Insulin is essential for the entry of glucose into which of the following tissues?
Which substance inhibits the glycolytic enzyme Enolase?
Which of the following statements is NOT true with respect to glycogen?
What is the threshold value for a high glycemic index?
All of the following are reducing sugars except?
Which of the following is NOT a product of the pentose phosphate pathway?
If only the terminal aldehyde group of glucose is oxidized, what is the product?
In which of the following steps of the TCA cycle is carbon dioxide removed?
Which one of the following is not associated with carbohydrate digestion or absorption?
What is the correct sequence of enzymatic events in glycogenolysis?
Explanation: **Explanation:** The entry of glucose into cells is mediated by a family of glucose transporters known as **GLUT**. The correct answer is **Skeletal muscles** because they primarily express **GLUT-4**, which is the only insulin-dependent glucose transporter. 1. **Why Skeletal Muscle is Correct:** In the resting state, GLUT-4 transporters are sequestered in intracellular vesicles. When insulin binds to its receptor, it triggers a signaling cascade that translocates these vesicles to the plasma membrane, allowing glucose uptake. This mechanism is also found in **Adipose tissue** and the **Heart**. 2. **Why Other Options are Incorrect:** * **Neurons (Cerebral Cortex):** Use **GLUT-3** (and GLUT-1), which has a high affinity for glucose and is insulin-independent, ensuring the brain receives glucose even during fasting. * **Renal Tubular Cells & Intestinal Mucosa:** These tissues utilize **SGLT-1 and SGLT-2** (Sodium-Glucose Linked Transporters) for active transport against a concentration gradient, and **GLUT-2** for facilitated diffusion. Both are insulin-independent. **NEET-PG High-Yield Pearls:** * **GLUT-1:** Found in RBCs and the Blood-Brain Barrier (Basal uptake). * **GLUT-2:** Bidirectional transporter found in the **Liver, Pancreas (B-cells), and Kidney**. It acts as a glucose sensor. * **GLUT-4:** The only **insulin-responsive** transporter (Muscle, Fat). * **GLUT-5:** Specifically a **Fructose** transporter found in the small intestine and spermatozoa. * **Exercise** can also trigger GLUT-4 translocation in skeletal muscle independent of insulin, which is why exercise helps manage Blood Glucose in Type 2 Diabetes.
Explanation: **Explanation:** **Enolase** is a key glycolytic enzyme that catalyzes the dehydration of 2-phosphoglycerate to phosphoenolpyruvate (PEP). **1. Why Fluoride is Correct:** Fluoride acts as a potent competitive inhibitor of Enolase. It binds with magnesium ($Mg^{2+}$) and inorganic phosphate to form a **magnesium-fluorophosphate complex**. Since Enolase requires $Mg^{2+}$ as a cofactor for its catalytic activity, this complex displaces the free magnesium, effectively trapping the enzyme and halting glycolysis. **2. Analysis of Incorrect Options:** * **Iodoacetate (A):** This inhibits **Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)** by reacting with the essential -SH (sulfhydryl) group at the enzyme's active site. * **Arsenate (C):** This acts as a structural analog of inorganic phosphate. It competes with phosphate in the GAPDH reaction, leading to the formation of 1-arseno-3-phosphoglycerate. This bypasses the synthesis of 1,3-bisphosphoglycerate, resulting in **zero net ATP production** during glycolysis (uncoupling). * **Arsenic/Arsenite (D):** Trivalent arsenic (arsenite) primarily inhibits the **Pyruvate Dehydrogenase (PDH) complex** and $\alpha$-ketoglutarate dehydrogenase by binding to the thiol groups of lipoic acid. **3. Clinical Pearls for NEET-PG:** * **Blood Glucose Estimation:** In clinical practice, blood samples for glucose testing are collected in **Grey-top tubes** containing **Sodium Fluoride (NaF)** and Potassium Oxalate. Fluoride prevents "in vitro" glycolysis by RBCs, ensuring the measured glucose level remains stable. * **Water Fluoridation:** While fluoride inhibits bacterial enolase (preventing dental caries), excessive intake leads to **Fluorosis**, characterized by mottled enamel and skeletal deformities.
Explanation: ### Explanation The correct answer is **D**. This statement is false because **insulin inhibits glycogenolysis** and stimulates glycogenesis. #### 1. Why Option D is the Correct Choice (The False Statement) Insulin is an anabolic hormone secreted by the pancreatic $\beta$-cells in the fed state. Its primary goal is to lower blood glucose levels. It achieves this by: * **Stimulating Glycogenesis:** Activating glycogen synthase. * **Inhibiting Glycogenolysis:** Deactivating glycogen phosphorylase through dephosphorylation (via protein phosphatase-1). In contrast, **Glucagon** and **Epinephrine** are the hormones that stimulate glycogenolysis to increase blood glucose during fasting or stress. #### 2. Analysis of Other Options * **Option A:** Glycogen is indeed the primary storage polysaccharide in humans (analogous to starch in plants), providing a rapidly mobilizable source of glucose. * **Option B:** While most cells contain some glycogen, the **liver** (maintains blood glucose) and **skeletal muscle** (provides energy for contraction) are the major reservoirs. * **Option C:** Glycogenesis is the biochemical pathway that synthesizes glycogen from glucose-6-phosphate. #### 3. NEET-PG High-Yield Pearls * **Rate-Limiting Enzymes:** Glycogen Synthase (Glycogenesis) and Glycogen Phosphorylase (Glycogenolysis). * **Linkage Types:** $\alpha(1\to4)$ glycosidic bonds form the linear chain; $\alpha(1\to6)$ bonds create branches (via Branching Enzyme). * **Tissue Specificity:** Muscle glycogen cannot maintain blood glucose because muscles lack the enzyme **Glucose-6-Phosphatase**. * **Clinical Correlation:** Von Gierke’s Disease (GSD Type I) is caused by a deficiency in Glucose-6-Phosphatase, leading to severe hypoglycemia and hepatomegaly.
Explanation: ### Explanation The **Glycemic Index (GI)** is a ranking system (0–100) that measures how quickly a carbohydrate-containing food increases blood glucose levels compared to a reference food (usually pure glucose or white bread). **1. Why Option C (70) is Correct:** According to the World Health Organization (WHO) and international standards, carbohydrates are categorized into three tiers based on their GI value: * **Low GI:** ≤ 55 (e.g., whole grains, legumes, most fruits) * **Medium GI:** 56–69 (e.g., brown rice, sweet potato) * **High GI:** **≥ 70** (e.g., white bread, white rice, glucose) Foods with a GI of 70 or above cause a rapid spike in blood glucose and insulin levels, making them less ideal for patients with diabetes or metabolic syndrome. **2. Why Other Options are Incorrect:** * **Option A (55):** This is the upper limit for **Low GI** foods. * **Option B (60):** This falls within the **Medium GI** range (56–69). * **Option D (100):** This is the **reference value** assigned to pure glucose. While it is a high GI value, it is not the *threshold* (starting point) for the high category. **3. Clinical Pearls for NEET-PG:** * **Glycemic Load (GL):** A more accurate clinical predictor than GI because it accounts for the **portion size** (GL = GI × grams of carbohydrate / 100). * **Factors affecting GI:** Particle size (smaller = higher GI), fiber content (higher = lower GI), and acidity (lowers GI by slowing gastric emptying). * **Clinical Utility:** Low GI diets are recommended in **Diabetes Mellitus** and **PCOS** to improve insulin sensitivity and reduce postprandial hyperglycemia.
Explanation: ### Explanation **The Concept: Reducing vs. Non-Reducing Sugars** A sugar is classified as "reducing" if it has a free or potentially free **anomeric carbon** (aldehyde or ketone group). This group allows the sugar to act as a reducing agent, donating electrons to reagents like Benedict’s or Fehling’s solution (reducing $Cu^{2+}$ to $Cu^+$). **Why Sucrose is the Correct Answer:** Sucrose is a disaccharide composed of **Glucose and Fructose**. The glycosidic linkage occurs between the anomeric carbon of glucose (C1) and the anomeric carbon of fructose (C2). Since both functional groups are locked in the bond, there is **no free anomeric carbon** available to reduce reagents. Therefore, sucrose is a **non-reducing sugar**. **Analysis of Incorrect Options:** * **Glucose (Option A):** A monosaccharide with a free aldehyde group at C1. All monosaccharides are reducing sugars. * **Lactose (Option B):** A disaccharide (Glucose + Galactose) with a $\beta(1\to4)$ linkage. The anomeric carbon of the glucose residue remains free, making it a reducing sugar. * **Maltose (Option C):** A disaccharide (Glucose + Glucose) with an $\alpha(1\to4)$ linkage. One anomeric carbon is free, making it a reducing sugar. **NEET-PG High-Yield Pearls:** * **Clinical Test:** Benedict’s test is used to detect reducing sugars in urine (e.g., glucosuria in Diabetes Mellitus). * **Inversion:** Sucrose is also known as **"Invert Sugar"** because its optical rotation changes from dextrorotatory to levorotatory upon hydrolysis. * **Trehalose:** Another high-yield non-reducing disaccharide (found in fungi/insects) where two glucose units are linked via their anomeric carbons ($1\to1$). * **Seliwanoff’s Test:** Used to distinguish Sucrose/Fructose (ketoses) from Glucose (aldose).
Explanation: The **Pentose Phosphate Pathway (PPP)**, also known as the Hexose Monophosphate (HMP) Shunt, is an alternative pathway for glucose oxidation that occurs in the cytosol. Its primary objectives are the generation of **NADPH** for reductive biosynthesis and **Ribose-5-phosphate** for nucleotide synthesis. ### Why O₂ is the Correct Answer Oxygen (**O₂**) is neither a substrate nor a product of the PPP. While the pathway is "oxidative" in its first phase, the oxidation is coupled with the reduction of NADP⁺ to NADPH, not the reduction of oxygen. Oxygen is typically involved in the electron transport chain (mitochondria) as the final electron acceptor, but it plays no role in the HMP shunt. ### Why Other Options are Incorrect * **Sedoheptulose-7-phosphate (Option A):** This is a 7-carbon intermediate produced during the **non-oxidative phase** by the enzyme transketolase. * **Glyceraldehyde-3-phosphate (Option C):** This is a 3-carbon glycolytic intermediate produced in the non-oxidative phase. It allows the PPP to link back to glycolysis. * **NADPH (Option D):** This is the most important product of the **oxidative phase**, generated by Glucose-6-Phosphate Dehydrogenase (G6PD) and 6-Phosphogluconate Dehydrogenase. ### NEET-PG High-Yield Pearls * **Rate-limiting enzyme:** Glucose-6-Phosphate Dehydrogenase (G6PD). * **Clinical Correlation:** G6PD deficiency leads to hemolytic anemia because RBCs cannot generate enough NADPH to maintain reduced glutathione, which is essential for neutralizing reactive oxygen species (ROS). * **Tissues involved:** Highly active in the liver, adrenal cortex, lactating mammary glands (fatty acid/steroid synthesis), and RBCs. * **Transketolase:** Requires **Thiamine (Vitamin B1)** as a cofactor; measuring its activity is used to diagnose thiamine deficiency.
Explanation: ### Explanation The oxidation of glucose can yield different sugar acids depending on which carbon atom is oxidized. **1. Why Gluconic Acid is Correct:** Glucose is an aldose sugar with an aldehyde group at **Carbon-1 (C1)** and a primary alcohol group at **Carbon-6 (C6)**. When **only the terminal aldehyde group (C1)** is oxidized to a carboxyl group (-COOH), the resulting compound is **Gluconic acid**. This reaction is catalyzed by the enzyme glucose oxidase and is the fundamental principle behind many glucose estimation tests. **2. Analysis of Incorrect Options:** * **Glucuronic acid:** This is formed when **only the terminal primary alcohol group (C6)** is oxidized, leaving the aldehyde group intact. It is crucial for detoxification (conjugation) in the liver. * **Glucosaccharic acid (Glucaric acid):** This is a dicarboxylic acid formed when **both the C1 (aldehyde) and C6 (primary alcohol)** groups are oxidized simultaneously (usually by strong oxidizing agents like concentrated nitric acid). * **Gluconolactone:** This is an intermediate cyclic ester formed during the oxidation of glucose (specifically in the Pentose Phosphate Pathway) before it is hydrolyzed to gluconic acid. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Uronic Acid Pathway:** Glucuronic acid is the precursor for **bilirubin conjugation** and the synthesis of **Glycosaminoglycans (GAGs)**. * **Essential Pentosuria:** A deficiency of L-xylulose reductase in the uronic acid pathway leads to the excretion of L-xylulose in urine (a benign condition). * **Sorbitol Pathway:** While oxidation produces acids, the **reduction** of the glucose aldehyde group produces **Sorbitol** (polyol), which is implicated in diabetic complications like cataracts and neuropathy. * **Benedict’s Test:** This test relies on the oxidation of the aldehyde group to a carboxyl group, reducing cupric ions to cuprous oxide.
Explanation: **Explanation:** In the TCA cycle (Krebs cycle), carbon dioxide is released during **oxidative decarboxylation** reactions. These steps are critical because they reduce the carbon chain length while generating reducing equivalents (NADH). **Why Option A is Correct:** The conversion of **$\alpha$-ketoglutarate (5C) to Succinyl-CoA (4C)** is catalyzed by the **$\alpha$-ketoglutarate dehydrogenase complex**. This is the second oxidative decarboxylation step of the cycle, where one molecule of $CO_2$ is removed and one molecule of $NAD^+$ is reduced to $NADH$. This enzyme complex is structurally similar to the Pyruvate Dehydrogenase (PDH) complex and requires five cofactors: Thiamine (B1), Riboflavin (B2), Niacin (B3), Pantothenic acid (B5), and Lipoic acid. **Why Other Options are Incorrect:** * **B. Malate dehydrogenase:** Catalyzes the conversion of Malate to Oxaloacetate. It generates NADH but does **not** involve decarboxylation. * **C. Succinate dehydrogenase:** Converts Succinate to Fumarate. This step generates **$FADH_2$** and is unique because the enzyme is embedded in the inner mitochondrial membrane (Complex II of ETC). No $CO_2$ is released. * **D. Fumarase:** Catalyzes the hydration of Fumarate to Malate. This is a simple hydration reaction involving no redox changes or $CO_2$ release. **High-Yield NEET-PG Pearls:** 1. **Two $CO_2$ release steps:** 1) Isocitrate $\rightarrow$ $\alpha$-ketoglutarate (via Isocitrate Dehydrogenase) and 2) $\alpha$-ketoglutarate $\rightarrow$ Succinyl-CoA. 2. **Rate-limiting step:** Isocitrate Dehydrogenase is the primary rate-limiting enzyme of the TCA cycle. 3. **Arsenite Poisoning:** Arsenite inhibits $\alpha$-ketoglutarate dehydrogenase by binding to the -SH groups of **Lipoic acid**, leading to a buildup of $\alpha$-ketoglutarate.
Explanation: **Explanation:** The correct answer is **Enterokinase** (also known as enteropeptidase) because it is involved in **protein digestion**, not carbohydrate metabolism. **1. Why Enterokinase is the correct answer:** Enterokinase is an enzyme secreted by the mucosal cells of the duodenum. Its specific function is to convert the inactive zymogen **trypsinogen into active trypsin**. Once trypsin is activated, it triggers a cascade that activates other pancreatic proteases (chymotrypsin, carboxypeptidase). Therefore, it is a key regulator of protein digestion. **2. Why the other options are incorrect:** * **Amylase (Option A):** This is the primary enzyme for starch digestion. Salivary amylase initiates the process in the mouth, and pancreatic amylase continues it in the small intestine, breaking down polysaccharides into disaccharides. * **Sucrase (Option B):** This is a "brush border enzyme" located on the intestinal microvilli. It hydrolyzes sucrose into glucose and fructose, a vital step in carbohydrate digestion. * **Secondary Active Transport (Option C):** This is the mechanism for glucose and galactose absorption. They are transported across the luminal membrane via the **SGLT-1** (Sodium-Glucose Co-transporter 1), which relies on the sodium gradient maintained by the Na+/K+ ATPase pump. **Clinical Pearls for NEET-PG:** * **SGLT-1 vs. GLUT-5:** Glucose and Galactose use SGLT-1 (active), while **Fructose** is absorbed via **GLUT-5** (facilitated diffusion). * **Enterokinase Deficiency:** A rare genetic condition leading to severe protein malnutrition (hypoproteinemia and edema) despite normal pancreatic function. * **Rate-limiting step:** The absorption of carbohydrates is generally the rate-limiting step in their utilization, not the digestion.
Explanation: **Explanation:** Glycogenolysis is the biochemical breakdown of glycogen into glucose-1-phosphate and glucose. The process follows a specific sequential order due to the structural complexity of the branched glycogen molecule. 1. **Glycogen Phosphorylase:** This is the rate-limiting enzyme. It cleaves $\alpha$-1,4-glycosidic bonds from the non-reducing ends by adding inorganic phosphate, releasing glucose-1-phosphate. It stops acting when it reaches 4 glucose residues away from a branch point (forming a **limit dextrin**). 2. **Glucan Transferase:** This enzyme (part of the debranching complex) shifts a block of three glucose residues from the outer branch to the nearby straight chain, exposing the single glucose residue attached by an $\alpha$-1,6-linkage. 3. **Debranching Enzyme ($\alpha$-1,6-glucosidase):** This enzyme hydrolyzes the remaining single glucose residue at the $\alpha$-1,6-branch point, releasing **free glucose**. 4. **Glycogen Phosphorylase:** Once the branch is removed, phosphorylase resumes its action on the newly elongated straight chain. **Why other options are incorrect:** * **Options B & C:** These suggest that debranching or transferase activity occurs before the initial action of phosphorylase. Phosphorylase must first "trim" the chains down to the limit dextrin before the debranching complex can access the branch points. **High-Yield Clinical Pearls for NEET-PG:** * **Von Gierke Disease (Type I GSD):** Deficiency of Glucose-6-Phosphatase; presents with severe hypoglycemia and hepatomegaly. * **Cori Disease (Type III GSD):** Deficiency of **Debranching Enzyme**; results in the accumulation of abnormal glycogen with short outer branches (limit dextrinosis). * **McArdle Disease (Type V GSD):** Deficiency of **Muscle Glycogen Phosphorylase**; presents with exercise-induced cramps and myoglobinuria. * **Key Regulation:** Glycogen phosphorylase is activated by phosphorylation (via Phosphorylase Kinase) and inhibited by ATP and Glucose-6-Phosphate.
Carbohydrate Chemistry and Classification
Practice Questions
Glycolysis: Reactions and Regulation
Practice Questions
Gluconeogenesis: Reactions and Regulation
Practice Questions
Glycogen Metabolism: Synthesis and Breakdown
Practice Questions
Glycogen Storage Diseases
Practice Questions
Pentose Phosphate Pathway
Practice Questions
Metabolism of Fructose and Galactose
Practice Questions
Disorders of Fructose and Galactose Metabolism
Practice Questions
Blood Glucose Regulation
Practice Questions
Diabetes Mellitus: Biochemical Aspects
Practice Questions
Glycosylation and Glycoproteins
Practice Questions
Lactose Intolerance and Galactosemia
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free